CN104987317B - 一种合成3-卤甲基苯并呋喃类化合物的方法 - Google Patents

一种合成3-卤甲基苯并呋喃类化合物的方法 Download PDF

Info

Publication number
CN104987317B
CN104987317B CN201510316420.5A CN201510316420A CN104987317B CN 104987317 B CN104987317 B CN 104987317B CN 201510316420 A CN201510316420 A CN 201510316420A CN 104987317 B CN104987317 B CN 104987317B
Authority
CN
China
Prior art keywords
ice bath
nmr
petroleum ether
compounds
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510316420.5A
Other languages
English (en)
Other versions
CN104987317A (zh
Inventor
李毅
王雪凤
游毅
袁耀锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuzhou University
Original Assignee
Fuzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuzhou University filed Critical Fuzhou University
Priority to CN201510316420.5A priority Critical patent/CN104987317B/zh
Publication of CN104987317A publication Critical patent/CN104987317A/zh
Application granted granted Critical
Publication of CN104987317B publication Critical patent/CN104987317B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及一种合成3‑卤甲基苯并呋喃类化合物的方法,在氩气保护冰浴条件下,向一干燥反应管中依次加入2‑炔丙氧基苯胺类化合物0.5 mmol,丙酮3.0 mL,浓盐酸0.12 mL,搅拌5分钟后,向体系中加叔丁基亚硝酸酯0.08 mL,反应体系冰浴下搅拌15分钟后加入碘化钠0.2 mmol,补加丙酮7.0 mL,撤去冰浴,将体系升温至60℃,反应约9小时结束,停止搅拌,减压除去溶剂,柱层析,用淋洗剂乙酸乙酯和石油醚淋洗,收集组分制得3‑卤甲基苯并呋喃类化合物。

Description

一种合成3-卤甲基苯并呋喃类化合物的方法
技术领域
本发明属于合成化学领域,具体涉及一种碘化物作为添加剂引发的2-炔丙氧基苯胺类化合物的自由基环化卤化反应,该反应可以实现以2-炔丙氧基苯胺类化合物为原料一步高效地合成3-卤甲基苯并呋喃类化合物。
背景技术
3-卤甲基苯并呋喃类化合物作为一类重要的芳香化合物,是常见的合成药物结构单元,广泛存在于具有生物活性的天然产物。此类化合物除了本身具有重要的生理活性,同时又可以作为重要的有机合成中间体,在合成中具有潜在的应用价值。a)K.Nakano,H.Matsunaga,K.Sai,N.Soh and T.Imato,Anal.Chim.Acta.2006,578,93-99;b)K.Kim,K.Matsuura and N.Kimizuka,Bioorg.Med.Chem.2007,15,4311-4317.目前已知文献中以简单芳香类化合物为起始原料,合成对3-卤甲基苯并呋喃类化合物的报道很少,一类是使用3-(2H)-苯并呋喃酮类化合物为原料,在强碱的作用下,经历氯亚甲基化和异构化两步反应,生成3-卤甲基苯并呋喃类化合物。其中,由于起始原料易发生自身aldol反应,故反应收率通常小于10%。c)M.Ohno,M.Miyamoto,K.Hoshi,T.Takeda,N.Yamada and A.OhtakeJ.Med.Chem.2005,48,5279-5294.另一类是邻羟基苯乙酮类化合物经历六步转化生成3-卤甲基苯并呋喃类化合物。反应步骤中涉及到SeO2和二氯亚砜等环境污染严重的化学药品。d)P.V.Podea,M.I.Tos,C.Paizs and F.D.Irimie,Tetrahedron:Asymmetry 2008,19,500-511.这两类方法的缺点是步骤繁琐,反应产率低,副产物多,原料难制备。
因而发展一种步骤简单、原料廉价易得、操作方便,条件温和,底物适用范围广而且效率高的合成3-卤甲基苯并呋喃类化合物的方法是重点和难点。本发明人发展的以2-炔丙氧基苯胺类化合物为原料,在添加剂碘化物作用下合成3-卤甲基苯并呋喃类化合物的方法弥补了文献报道的不足,为一种简便实用的合成方法。
发明内容
本发明的目的是提供一种有效的合成3-卤甲基苯并呋喃类化合物的方法。
本发明的方法是一种有效的由2-炔丙氧基苯胺类化合物为起始原料合成3-卤甲基苯并呋喃类化合物的方法。
本发明的方法是一种有效的以碘化物作为添加剂,由2-炔丙氧基苯胺类化合物合成3-卤甲基苯并呋喃类化合物的方法。
本发明的方法所合成的3-卤甲基苯并呋喃类化合物分子通式是:
发明内容
本发明目的是要提供一种高效地合成3-卤甲基苯并呋喃类化合物的方法。
该方法是2-炔丙氧基苯胺类化合物为原料,在卤代氢和亚硝酸酯的存在下,以碘化物作为添加剂,反应3-48小时制得3-卤甲基苯并呋喃类化合物。
本发明的方法所使用的起始原料2-炔丙氧基苯胺类化合物的分子通式是:所合成的3-卤甲基苯并呋喃类化合物的分子通式是:
式中:R1、R2任意选自H、C1-C16的烷基、C3-C16的环烷基;C4-C10的含N、O或S的杂环基或者杂芳基、芳基、R取代的芳基;所述的芳基是苯基或萘基;R为C1-C4的烷基、C1-C4的全氟烷基、卤素或C1-C4的烷氧基;X为氯、溴或碘。
本发明的3-卤甲基苯并呋喃类化合物均是以2-炔丙氧基苯胺类化合物为原料,在亚硝酸酯、卤代氢和有机溶剂的存在下,以碘化物催化反应制得,可用下式表示:
所述的2-炔丙氧基苯胺类化合物的结构式为:其中R1、R2任意选自H、C1-C16的烷基、C3-C16的环烷基;C4-C10的含N、O或S的杂环基或杂芳基、芳基、R取代的芳基;所述的芳基是苯基或萘基;R为C1-C4的烷基、C1-C4的全氟烷基、卤素或C1-C4的烷氧基。
所述的卤代氢为:氯化氢(溶液或气体)、溴化氢(溶液或气体)或碘化氢(溶液或气体);
所述的亚硝酸酯类化合物结构式为:R3任意选自H、C1-C16的烷基、C3-C16的环烷基;C4-C10的含N、O或S的杂环基或杂芳基、芳基、R取代的芳基;所述的芳基是苯基或萘基;R为C1-C4的烷基、C1-C4的全氟烷基、卤素或C1-C4的烷氧基。
所述的碘化物为:碘化锂、碘化钠、碘化钾、碘化铯、碘化铵或四丁基碘化铵。
所述的2-炔丙氧基苯胺类化合物、卤代氢、亚硝酸酯、碘化物的摩尔比为1:1-5:1-5:0.1-1。尤其推荐反应摩尔比为1:2.5:1.1:0.4。
反应温度推荐为-20℃至120℃,进一步推荐反应温度为:40℃至60℃。
本发明中所提到的烷基、烃氧基、酰基等,除非另外说明,均推荐碳数为1~18的基团,进一步推荐碳数为1~10的,尤其推荐碳数为1~5的。本发明中所提到的环烷基,除非另外说明,均指碳数为3~18的基团,进一步推荐碳数为3~10的,尤其推荐碳数为3~7的。本发明中所提到的芳基,除非另外说明,均指苯基、C5~C10的含N、O或S的杂环基,推荐为苯基。本发明中提到的杂芳基,推荐C5~C10的含N、O和S的杂环基。
本发明方法中,所述有机溶剂可以是极性或非极性溶剂。如丙酮、乙腈、苯、四氯化碳、石油醚、四氢呋喃、二甲基亚砜、二甲基甲酰胺、乙醚、二氯甲烷、三氯甲烷、甲苯、二甲苯、环己烷、正己烷、正庚烷或二氧六环等。
采用本发明方法所得产物可以经过重结晶,薄层层析,柱层析或减压蒸馏等方法加以分离。如用重结晶的方法,推荐溶剂为极性溶剂与非极性溶剂的混合溶剂。推荐溶剂可为二氯甲烷―正己烷、异丙醇―石油醚、乙酸乙酯―石油醚、乙酸乙酯―正己烷或异丙醇―乙酸乙酯―石油醚等混合溶剂。用薄层层析和柱层析方法,所用的展开剂为非极性溶剂或者极性溶剂与非极性溶剂的混合溶剂。推荐溶剂可为石油醚、异丙醇―石油醚、乙酸乙酯―石油醚、乙酸乙酯―正己烷或异丙醇―乙酸乙酯―石油醚等混合溶剂,其体积比可以分别是:极性溶剂:非极性溶剂=1:0.1-500。例如:石油醚,乙酸乙酯:石油醚=1:0.1-100,异丙醇:石油醚=1:0.1-500。
本发明提供了一些新的3-卤甲基苯并呋喃类化合物其中例如R1为甲基、苯基、氨基、烷氧基;R2为甲基、苯基、对甲基苯基、苄基、烷基;X为氯、溴、碘。该类化合物可以经常规的金属偶联反应将X取代基进一步转换为烷基、芳基或杂芳基,从而具有广泛的应用。
本发明提供了一种高效的由2-炔丙氧基苯胺类化合物、亚硝酸酯和氢卤酸作用,现场生成的重氮盐,再以碘化物作为添加剂,高效率一步合成3-卤甲基苯并呋喃类化合物的方法。与现有方法相比,该方法可适用于多种不同类型的2-炔丙氧基苯胺类化合物,反应条件温和,原料廉价易得,操作简便,无重金属参与,从而有利于药物或者药物中间体的生产和处理。且反应的产率较好。
具体实施方式
通过下述实施例将有助于理解本发明,但并不限制本发明的内容。
在氩气保护冰浴条件下,向一干燥反应管中依次加入2-炔丙氧基苯胺类化合物(0.5mmol),丙酮(3.0mL),浓盐酸(0.12mL),搅拌5分钟后,向体系中加叔丁基亚硝酸酯(0.08mL),反应体系冰浴下搅拌15min后加入碘化钠(0.2mmol),补加丙酮7.0mL,撤去冰浴,将体系升温至60℃,反应约9h结束,停止搅拌,减压除去溶剂,柱层析,淋洗剂:乙酸乙酯和石油醚,收集组分,得相应产物A。A1:
石油醚淋洗;无色油状物,产率:77%;1H NMR(400MHz,CDCl3)δ7.69(d,J=7.6Hz,1H),7.66(s,1H),7.50(d,J=7.6Hz,1H),7.38-7.27(m,2H),4.75(s,2H).
A2:
石油醚淋洗;浅黄色油状物,产率:71%;1H NMR(400MHz,CDCl3)δ7.67(s,1H),7.41(dd,J=8.8,4.0Hz,1H),7.34(dd,J=8.2,2.6Hz,1H),7.05(td,J=8.8,2.6Hz,1H),4.69(s,2H).
A3:
石油醚淋洗;浅黄色油状物,产率:70%;1H NMR(400MHz,CDCl3)δ7.65(s,1H),7.60(dd,J=8.8,5.4Hz,1H),7.20(d,J=8.8Hz 1H),7.06(t,J=9.4Hz,1H),4.71(s,2H);13CNMR(101MHz,CDCl3)δ161.27(d,J=243.2Hz),155.6(d,J=13.6Hz),143.7(d,J=4.0Hz),122.6,120.4(d,J=10.2Hz),117.6,111.5(d,J=24.2Hz),99.5(d,J=26.8Hz),35.9;19FNMR(376MHz,CDCl3)δ-116.43(td,J=9.2,5.4Hz);IR(薄膜):νmax(cm-1)=3059,1670,1240,1191,1058,933,875,739;HRMS(EI)calcd for(M+)C9H6ClFO:184.0095,Found:184.0094.
A4:
石油醚淋洗;浅黄色油状物,产率:67%;1H NMR(400MHz,CDCl3)δ7.67(s,1H),7.66(s,1H),7.41(d,J=8.8Hz,1H),7.29(dd,J=8.8,1.8Hz,1H),4.70(s,2H).
A5:
石油醚淋洗;黄色油状物,产率:55%;1H NMR(400MHz,CDCl3)δ7.64(s,1H),7.38(d,J=8.8Hz,1H),7.11(d,J=2.4Hz,1H),6.94(dd,J=8.8,2.4Hz,1H),4.73(s,2H),3.87(s,3H).
A6:
石油醚淋洗;无色油状物,产率:76%;1H NMR(400MHz,CDCl3)δ7.61(s,1H),7.47(s,1H),7.37(d,J=8.4Hz,1H),7.14(d,J=8.4Hz,1H),4.72(s,2H),2.46(s,3H);13C NMR(101MHz,CDCl3)δ154.1,143.3,132.7,126.3,126.2,119.7,117.3,1113,36.3,21.4;IR(薄膜):νmax(cm-1)=3042,2920,1660,1423,1240,1058,983,739;HRMS(EI)calcd for(M+)C10H9ClO:180.0346,Found:180.0345.
A7:
石油醚淋洗;无色油状物,产率:45%;1H NMR(400MHz,CDCl3)δ7.88(t,J=9.0Hz,2H),7.51-7.34(m,3H),4.86(s,2H).
A8:
石油醚淋洗;无色油状物,产率:54%;1H NMR(400MHz,CDCl3)δ7.73(s,1H),7.63(dd,J=7.6,1.2Hz,1H),7.50(dd,J=8.0,1.2Hz,1H),7.18(t,J=7.6,8.0Hz,1H),4.72(s,2H);13C NMR(101MHz,CDCl3)δ152.8,143.7,128.1,127.6,124.4,119.2,118.6,104.6,35.8;IR(薄膜):νmax(cm-1)=3059,1660,1240,1062,840,873,739,609;HRMS(EI)calcd for(M+)C9H6BrClO:243.9291,Found:243.9293.
A9:
石油醚淋洗;无色油状物,产率:64%;1H NMR(400MHz,CDCl3)δ7.81(d,J=2.0Hz,1H),7.65(s,1H),7.42(dd,J=2.0,8.8Hz,1H),7.35(d,J=8.8Hz,1H),4.68(s,2H);13C NMR(101MHz,CDCl3)δ154.4,144.2,128.3,128.0,122.8,117.3,116.2,113.3,35.7;IR(薄膜):νmax(cm-1)=3059,1660,1240,1062,940,873,739,609;HRMS(EI)calcd for(M+)C9H6BrClO:243.9297,Found:243.9295.
A10:
乙酸乙酯/石油醚=1/50,v/v;无色油状物,产率:74%;1H NMR(400MHz,CDCl3)δ8.33(s,1H),8.01(d,J=8.0Hz,1H),7.75(s,1H),7.54(d,J=8.0Hz,1H),4.78(s,2H),2.69(s,3H);13C NMR(101MHz,CDCl3)δ197.5,158.1,144.5,132.9,126.4,125.7,121.2,118.5,111.8,35.6,26.8;IR(薄膜):νmax(cm-1)=3041,2920,1718,1660,1448,1240,1062,739;HRMS(ESI)calcd for(MH+)C11H10ClO2:209.0364,Found:209.0359.
A11:
乙酸乙酯/石油醚=1/100,v/v;无色油状物,产率:55%;1H NMR(400MHz,CDCl3)δ8.44(s,1H),8.09(d,J=8.0Hz,1H),7.75(s,1H),7.54(d,J=8.0Hz,1H),4.78(s,2H),3.98(s,3H);13C NMR(101MHz,CDCl3)δ167.0,158.1,144.4,126.8,126.3,125.5,122.5,118.3,111.6,52.4,35.5;IR(薄膜):νmax(cm-1)=3059,1720,1595,1240,1103,1072,933,739;HRMS(ESI)calcd for(MH+)C11H10ClO3:225.0313,Found:225.0308.
A12:
石油醚淋洗;无色油状物,产率:72%;1H NMR(400MHz,CDCl3)δ7.68(d,J=7.8Hz,1H),7.60(s,1H),7.51(d,J=7.8Hz,1H),7.39-7.25(m,2H),4.85(q,J=2.6Hz,1H),1.90(d,J=2.6Hz,3H);13C NMR(101MHz,CDCl3)δ155.6,142.2,129.3,124.4,123.0,119.9,115.7,111.8,53.6,28.5;IR(薄膜):νmax(cm-1)=3059,2976,1640,1462,1255,1072,933,739;HRMS(EI)calcd for(M+)C10H9ClO:180.0342,Found:180.0344.
A13:
石油醚淋洗;无色油状物,产率:60%;1H NMR(400MHz,CDCl3)δ7.76(d,J=8.8Hz,1H),7.67(s,1H),7.60(d,J=8.8Hz,1H),7.49-7.28(m,7H),5.95(s,1H);13C NMR(101MHz,CDCl3)δ155.7,141.2,133.1,129.4,128.3,127.9,124.2,123.7,119.0,116.3,111.8;IR(薄膜):νmax(cm-1)=3059,2998,1640,1452,1235,1072,933,739;HRMS(EI)calcd for(M+)C15H11ClO:242.0498,Found:242.0497.
在氩气保护下,冰浴条件下,向一干燥反应管中依次加入2-炔丙氧基苯胺类化合物(0.5mmol),丙酮3.0mL,氢溴酸的乙酸溶液(0.18mL),搅拌5分钟后,向体系中加叔丁基亚硝酸酯(0.08mL)。反应体系冰浴下搅拌15min后加入碘化钠(0.2mmol),补加丙酮7.0mL,撤去冰浴,体系升温至60℃,反应约9h结束,停止搅拌,减压除去溶剂,饱和硫代硫酸钠水溶液洗涤,二氯甲烷萃取,无水硫酸钠干燥,减压除去溶剂,柱层析,淋洗剂:乙酸乙酯和石油醚,收集组分,得相应产物B。
B1:
石油醚淋洗;无色油状物,产率:68%;1H NMR(400MHz,CDCl3)δ7.72-7.65(m,2H),7.48(dt,J=6.7,3.6Hz,1H),7.42-7.34(m,2H),4.61(s,2H).
B2:
石油醚淋洗;浅黄色油状物,产率:69%;1H NMR(400MHz,CDCl3)δ7.80(s,1H),7.57(dd,J=8.8,3.8Hz,1H),7.44(dd,J=8.0,2.6Hz,1H),7.10(td,J=8.8,2.6Hz,1H),4.62(s,2H);13C NMR(101MHz,CDCl3)δ159.3(d,J=239.4Hz),151.8,144.8,127.1(d,J=10.6Hz),117.9(d,J=4.0Hz),112.9(d,J=26.4Hz),112.5(d,J=9.6Hz),105.7(d,J=25.4Hz),35.9;19F NMR(376MHz,CDCl3)δ-119.9(td,J=8.8,4.0Hz);IR(薄膜):νmax(cm-1)=3029,1671,1244,1190,1065,933,875,608;HRMS(EI)calcd for(M+)C9H6BrFO:227.9586,Found:227.9588.
B3:
石油醚淋洗;浅黄色油状物,产率:63%;1H NMR(400MHz,CDCl3)δ7.74(s,1H),7.62(dd,J=9.0,5.2Hz,1H),7.19(d,J=9.0Hz,1H),7.08(t,J=9.6Hz,1H),4.73(s,2H);13CNMR(101MHz,CDCl3)δ161.27(d,J=245.0Hz),155.6(d,J=13.2Hz),143.7(d,J=4.4Hz),122.2,120.6(d,J=10.2Hz),116.6,110.9(d,J=24.8Hz),99.0(d,J=25.8Hz),36.0;19FNMR(376MHz,CDCl3)δ-115.40(td,J=9.0,5.2Hz);IR(薄膜):νmax(cm-1)=3029,1671,1244,1190,1065,933,875,608;HRMS(EI)calcd for(M+)C9H6BrFO:227.9586,Found:227.9588.
B4:
石油醚淋洗;无色油状物,产率:70%;1H NMR(400MHz,CDCl3)δ7.67(d,J=10.0Hz,2H),7.40(dd,J=8.8,1.0Hz,1H),7.29(d,J=8.8Hz,1H),4.56(s,2H);13C NMR(101MHz,CDCl3)δ154.0,144.4,128.8,127.7,125.4,119.8,117.6,112.8,21.7;IR(薄膜):νmax(cm-1)=3029,1671,1244,1065,930,835,680,608;HRMS(EI)calcd for(M+)C9H6BrClO:243.9291,Found:243.9293.
B5:
石油醚淋洗;黄色油状物,产率:61%;1H NMR(400MHz,CDCl3)δ7.63(s,1H),7.32(d,J=8.8,1H),7.11(d,J=2.2Hz,1H),6.93(dd,J=8.8,2.2Hz,1H),4.75(s,2H),3.86(s,3H).
B6:
石油醚淋洗;无色油状物,产率:64%;1H NMR(400MHz,CDCl3)δ7.62(s,1H),7.47(s,1H),7.36(d,J=8.4Hz,1H),7.13(d,J=8.4Hz,1H),4.59(s,2H),2.46(s,3H);13C NMR(101MHz,CDCl3)δ154.1,143.3,132.7,126.4,119.7,117.5,111.3,22.6,21.5;IR(薄膜):νmax(cm-1)=3029,2923,1671,1422,1244,1190,1065,608;HRMS(EI)calcd for(M+)C10H9BrO:223.9837,Found:223.9835.
B7:
石油醚淋洗;无色油状物,产率:56%;1H NMR(400MHz,CDCl3)δ7.88(t,J=9.0Hz,2H),7.50-7.38(m,3H),4.89(s,2H).
B8:
石油醚淋洗;无色油状物,产率:62%;1H NMR(400MHz,CDCl3)δ7.73(s,1H),7.61(dd,J=7.6,1.0Hz,1H),7.50(dd,J=8.0,1.0Hz,1H),7.22(t,J=7.6,8.0Hz,1H),4.71(s,2H);13C NMR(101MHz,CDCl3)δ153.8,143.0,128.8,127.3,124.2,118.9,118.3,104.6,34.9;IR(薄膜):νmax(cm-1)=3029,1671,1244,1065,933,876,675,608;HRMS(EI)calcd for(M+)C9H6Br2O:287.8785,Found:287.8783.
B9:
石油醚淋洗;无色油状物,产率:73%;1H NMR(400MHz,CDCl3)δ7.82(d,J=1.6Hz,1H),7.67(s,1H),7.43(dd,J=8.8,1.6Hz,1H),7.35(d,J=8.8Hz,1H),4.56(s,2H).13C NMR(101MHz,CDCl3)δ154.4,144.2,128.3,128.1,122.8,117.5,116.2,113.3,21.6.;IR(薄膜):νmax(cm-1)=3029,1671,1244,1065,933,875,675,608;HRMS(EI)calcd for(M+)C9H6Br2O:287.8785,Found:287.8783.
B10:
乙酸乙酯/石油醚=1/50,v/v;无色油状物,产率:76%;1H NMR(400MHz,CDCl3)δ8.33(s,1H),8.08(d,J=8.0Hz,1H),7.74(s,1H),7.55(d,J=8.0Hz,1H),4.79(s,2H),2.63(s,3H);13C NMR(101MHz,CDCl3)δ198.5,159.0,144.8,133.9,126.7,125.3,121.3,118.5,111.2,35.6,26.4;IR(薄膜):νmax(cm-1)=3029,2923,1720,1671,1422,1244,1065,608;HRMS(ESI)calcd for(MH+)C11H10BrO2:252.9859,Found:252.9855.
B11:
乙酸乙酯/石油醚=1/100,v/v;无色油状物,产率:64%;1H NMR(400MHz,CDCl3)δ8.42(s,1H),8.07(dd,J=8.8,1.4Hz,1H),7.75(s,1H),7.51(d,J=8.8Hz,1H),4.62(s,2H),3.95(s,3H);13C NMR(101MHz,CDCl3)δ167.0,158.1,144.4,126.8,126.4,125.5,122.4,118.4,111.7,52.3,21.4;IR(薄膜):νmax(cm-1)=3029,1722,1590,1244,1103,1065,875,608;HRMS(ESI)calcd for(MH+)C11H10BrO3:268.9808,Found:268.9805.
在氩气保护下,冰浴条件下,向一干燥反应管中依次加入2-炔丙氧基苯胺类化合物(0.5mmol),丙酮3.0mL,碘化氢的水溶液(0.15mL),搅拌5分钟后,向体系中加入叔丁基亚硝酸酯(0.08mL)。反应体系于冰浴下搅拌15min后加入碘化钠(0.2mmol),补加丙酮7.0mL,撤去冰浴,体系升温至60℃,反应约9h结束,停止搅拌,减压除去溶剂,饱和硫代硫酸钠水溶液洗涤,二氯甲烷萃取,无水硫酸钠干燥,减压除去溶剂,柱层析,淋洗剂:乙酸乙酯和石油醚,收集组分,得相应产物C。
C1:
石油醚淋洗;无色油状物,产率:70%;1H NMR(400MHz,CDCl3)δ7.76(d,J=7.6Hz,1H),7.65(s,1H),7.51(d,J=7.6Hz,1H),7.34-7.27(m,2H),4.55(s,2H);13C NMR(101MHz,CDCl3)δ154.2,143.2,128.8,127.3,124.5,119.8,117.6,111.5,7.2;IR(薄膜):νmax(cm-1)=3029,1661,1500,1244,1134,930,835,588;HRMS(EI)calcd for(M+)C9H7IO:257.9542,Found:257.9540.
C2:
石油醚淋洗;无色油状物,产率:72%;1H NMR(400MHz,CDCl3)δ7.67(d,J=10.0Hz,2H),7.40(dd,J=8.6,1.0Hz,1H),7.29(d,J=8.6Hz,1H),4.47(s,2H);13C NMR(101MHz,CDCl3)δ155.2,142.4,129.8,127.3,125.4,119.8,117.6,111.5,7.2;IR(薄膜):νmax(cm-1)=3029,1661,1244,1134,930,835,720,588;HRMS(EI)calcd for(M+)C9H6ClIO:291.9152,Found:291.9151.

Claims (1)

1.一种合成3-卤甲基苯并呋喃类化合物的方法,其特征是在氩气保护冰浴条件下,向一干燥反应管中依次加入2-炔丙氧基苯胺类化合物0.5mmol,丙酮3.0mL,浓盐酸0.12mL,搅拌5分钟后,向体系中加叔丁基亚硝酸酯0.08mL,反应体系冰浴下搅拌15分钟后加入碘化钠0.2mmol,补加丙酮7.0mL,撤去冰浴,将体系升温至60℃,反应约9小时结束,停止搅拌,减压除去溶剂,柱层析,用淋洗剂乙酸乙酯和石油醚淋洗,收集组分制得3-卤甲基苯并呋喃类化合物;
所述的2-炔丙氧基苯胺类化合物结构式为:其中,R1、R2任意选自含有H、F、Cl、Br基团的C1-C16的烷基,或者含有H、F、Cl、Br基团的C3-C16的环烷基;
所述的叔丁基亚硝酸酯结构式为:其中R3为叔丁基;
所述合成3-卤甲基苯并呋喃类化合物结构式为的化合物,其中,X为:氯。
CN201510316420.5A 2015-06-11 2015-06-11 一种合成3-卤甲基苯并呋喃类化合物的方法 Expired - Fee Related CN104987317B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510316420.5A CN104987317B (zh) 2015-06-11 2015-06-11 一种合成3-卤甲基苯并呋喃类化合物的方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510316420.5A CN104987317B (zh) 2015-06-11 2015-06-11 一种合成3-卤甲基苯并呋喃类化合物的方法

Publications (2)

Publication Number Publication Date
CN104987317A CN104987317A (zh) 2015-10-21
CN104987317B true CN104987317B (zh) 2019-03-01

Family

ID=54299238

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510316420.5A Expired - Fee Related CN104987317B (zh) 2015-06-11 2015-06-11 一种合成3-卤甲基苯并呋喃类化合物的方法

Country Status (1)

Country Link
CN (1) CN104987317B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114751882B (zh) * 2022-03-10 2024-02-23 南京工业大学 一种苯并呋喃的合成方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Chemoenzymatic preparation of enantiopure L-benzofuranyl-and L-benzo[b]thiophenyl alanines;Paula Veronica Podea 等人;《Tetrahedron:Asymmetry》;20081231;第19卷(第2008期);第500-511页

Also Published As

Publication number Publication date
CN104987317A (zh) 2015-10-21

Similar Documents

Publication Publication Date Title
CN104892387B (zh) 一种合成氟代芴酮类化合物的方法
Yanai et al. Indium (III) triflate catalyzed tandem azidation/1, 3-dipolar cycloaddition reaction of ω, ω-dialkoxyalkyne derivatives with trimethylsilyl azide
Chang et al. Direct nucleophilic fluorination of carbonyl groups of benzophenones and benzils with Deoxofluor
CN104987317B (zh) 一种合成3-卤甲基苯并呋喃类化合物的方法
Zielinska et al. A solvent-free synthesis of (dichloroiodo) arenes from iodoarenes
CN105949147B (zh) 一种绿色合成2-巯基苯并噻唑类衍生物的方法
Wu et al. DABCO-mediated one-pot sequential transformation: convenient access to fluorinated 1H-pyrazol-5 (4H)-ones
CN109293593A (zh) 一种合成碘代异噁唑啉类化合物的方法
Maekawa et al. Selective introduction of a trifluoroacetyl group onto 4-vinylpyridines through magnesium-promoted reduction
Fedorov et al. Synthesis of difluorosubstituted six-membered nitronates via an addition/substitution cascade
CN109574913A (zh) 一种用硝酸盐水合物制备偕二硝基化合物的方法
CN105037304B (zh) 一种合成3-卤亚甲基-2,3-二氢苯并呋喃类化合物的方法
Yang et al. Selective syntheses of benzoxazoles and N-(2-hydroxyaryl) pyrrolidin-2-ones from the corresponding cyclopropyl amides with PPh3/CX4
CN108358865B (zh) 一种多取代噻唑类化合物的制备方法
Hanamoto et al. Synthesis and reactions of 5-tributylstannyl-4-fluoro-1H-pyrazole
Liu et al. Synthesis of trifluoromethyl-/cyclopropyl-substituted 2-isoxazolines by DBU-promoted domino reaction
CN105017188B (zh) 一种合成3-卤甲基-2,3-二氢苯并呋喃类化合物的方法
Harsanyi et al. α‐Fluorotricarbonyl Derivatives as Versatile Fluorinated Building Blocks: Synthesis of Fluoroacetophenone, Fluoroketo Ester and Fluoropyran‐4‐one Derivatives
CN104844410B (zh) 一种1,1‑二氟‑1,3‑烯炔化合物的合成方法
CN103351340B (zh) 唑虫酰胺的新制备方法
CN105189467B (zh) 制备哒嗪酮化合物的方法
Wu et al. One-pot synthesis of bromodifluoroacetimidoyl halides and its Suzuki coupling reactions with aryl boronic acids
CN111018807A (zh) 一种合成1,2,4-噻二唑衍生物的方法
CN107663149A (zh) 一种菲醌及其衍生物的制备方法
CN106866488B (zh) 一种3,3-二氟-4-吡咯啉-2-酮化合物的合成方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190301

Termination date: 20200611

CF01 Termination of patent right due to non-payment of annual fee